Leveljump Healthcare Corp. (TSXV:JUMP) entered into an agreement to acquire additional 10.44% stake in Médical Temps Réel inc. for CAD 0.99 million on April 26, 2022. Under the terms of the purchase agreement, the company has agreed to acquire all of the outstanding shares of 7127651 Canada Inc. 7127651 is a holding company with its principal asset being 1,784,364 common shares of Real Time Medical Inc. The company has agreed to pay to the vendor total consideration of CAD 963,556.56 consisting of: (i) cash in the amount of CAD 579,918 payable in 3 instalments over four months; and (ii) 2,557,590 common shares of the company at a deemed issue price of CAD 0.15 per share with an aggregate value of CAD 383,638.56. One-half of the consideration shares will be subject to a contractual hold period of 180 days from closing with the balance of the consideration shares releasable one year after closing. In addition to the purchase of the shares of 7127651, the company has agreed to purchase from the vendor for the sum of CAD 50,000, a promissory note of RTM in the principal amount of CAD 50,000 with any accrued interest. Upon closing of the purchase agreement, Leveljump will own directly and indirectly, a 35.99% interest in RTM. Closing of the purchase agreement and the issuance of the consideration shares is subject to the acceptance of the TSX Venture Exchange.

Leveljump Healthcare Corp. (TSXV:JUMP) cancelled the acquisition of additional 10.44% stake in Médical Temps Réel inc. on July 5, 2022. Although the company obtained TSXV approval, it was unable to proceed with the transaction as a result of certain corporate actions taken against the company by RTM to impede closing. In response to the conduct of RTM, the company has commenced legal proceedings in the Ontario Superior Court of Justice against RTM and its management.